# Efficacy of an Intravitreal DEX Implant in Retinal Vein Occlusion Following Treatment With Anti-VEGF Injections.

> **NCT01449682** · PHASE3 · COMPLETED · sponsor: **Retina Macula Institute** · enrollment: 10 (actual)

## Conditions studied

- Retinal Vein Occlusion
- Macular Edema

## Interventions

- **DRUG:** Ozurdex
- **DRUG:** Ozurdex

## Key facts

- **NCT ID:** NCT01449682
- **Lead sponsor:** Retina Macula Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2012-07
- **Final completion:** 2013-02
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2017-05-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01449682

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01449682, "Efficacy of an Intravitreal DEX Implant in Retinal Vein Occlusion Following Treatment With Anti-VEGF Injections.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01449682. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*